CD8A and melanoma: The results from the current study show that ex vivo transduction of DCs in SLN cell suspensions from melanoma patients by Ad5/3-MART-1 facilitated the expansion of TAA-specific CD8+ T cells leading to higher frequencies of MART-126–35L-specific T cells compared to the wild-type Ad5-MART-1.